Evaluation of the Allergenicity of AMPHADASE INJECTION (Hyaluronidase Injection USP)

NCT01689363 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
253
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Amphastar Pharmaceuticals, Inc.